Sanofi (EPA:SAN)

Sanofi Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	41,081	37,817	37,651	37,761	36,041
Other Revenue	3,205	3,292	2,653	1,414	1,328
Revenue	44,286	41,109	40,304	39,175	37,369
Revenue Growth (YoY)	7.73%	2.00%	2.88%	4.83%	-0.70%
Cost of Revenue	13,195	12,619	11,869	12,251	12,106
Gross Profit	31,091	28,490	28,435	26,924	25,263
Selling, General & Admin	9,247	9,003	8,785	9,599	9,448
Research & Development	7,394	6,507	6,501	5,692	5,530
Other Operating Expenses	3,832	2,948	1,190	1,488	1,025
Operating Expenses	22,222	20,369	18,054	18,359	17,684
Operating Income	8,869	8,121	10,381	8,565	7,579
Interest Expense	-641	-589	-402	-362	-459
Interest & Investment Income	413	527	239	3	37
Earnings From Equity Investments	60	-136	55	39	359
Currency Exchange Gain (Loss)	6	-2	-3	2	-6
Other Non Operating Income (Expenses)	-268	-574	-14	70	144
EBT Excluding Unusual Items	8,439	7,347	10,256	8,317	7,654
Merger & Restructuring Charges	-1,406	-1,039	-1,090	-824	-1,142
Gain (Loss) on Sale of Investments	-	-1	1	3	7,388
Gain (Loss) on Sale of Assets	539	484	481	418	443
Asset Writedown	-248	-896	203	-192	-330
Legal Settlements	-470	-196	-143	-	-
Other Unusual Items	-96	416	284	115	124
Pretax Income	6,758	6,115	9,992	7,837	14,137
Income Tax Expense	1,204	1,017	1,909	1,558	1,807
Earnings From Continuing Operations	5,554	5,098	8,083	6,279	12,330
Earnings From Discontinued Operations	64	338	401	-	-
Net Income to Company	5,618	5,436	8,484	6,279	12,330
Minority Interest in Earnings	-58	-36	-113	-56	-36
Net Income	5,560	5,400	8,371	6,223	12,294
Net Income to Common	5,560	5,400	8,371	6,223	12,294
Net Income Growth	2.96%	-35.49%	34.52%	-49.38%	346.41%
Shares Outstanding (Basic)	1,251	1,252	1,252	1,253	1,254
Shares Outstanding (Diluted)	1,256	1,256	1,257	1,258	1,260
Shares Change (YoY)	-0.02%	-0.04%	-0.08%	-0.17%	0.24%
EPS (Basic)	4.44	4.31	6.69	4.97	9.81
EPS (Diluted)	4.44	4.31	6.67	4.95	9.76
EPS Growth	2.94%	-35.31%	34.73%	-49.28%	345.73%
Free Cash Flow	5,886	7,352	8,423	9,044	6,164
Free Cash Flow Per Share	4.69	5.85	6.70	7.19	4.89
Dividend Per Share	3.920	3.760	3.560	3.330	3.200
Dividend Growth	4.26%	5.62%	6.91%	4.06%	1.59%
Gross Margin	70.20%	69.30%	70.55%	68.73%	67.60%
Operating Margin	20.03%	19.75%	25.76%	21.86%	20.28%
Profit Margin	12.55%	13.14%	20.77%	15.89%	32.90%
Free Cash Flow Margin	13.29%	17.88%	20.90%	23.09%	16.49%
EBITDA	11,664	11,076	13,093	11,251	10,466
EBITDA Margin	26.34%	26.94%	32.49%	28.72%	28.01%
D&A For EBITDA	2,795	2,955	2,712	2,686	2,887
EBIT	8,869	8,121	10,381	8,565	7,579
EBIT Margin	20.03%	19.75%	25.76%	21.86%	20.28%
Effective Tax Rate	17.82%	16.63%	19.11%	19.88%	12.78%

Source: S&P Capital IQ. Standard template. Financial Sources.